Jeffrey D Capello insider trades
Open-market stock purchases and sales by Jeffrey D Capello, Director at Agios Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 16, 2010.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +147%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 18, 2026 | AGIO Agios Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 18, 2026 | AGIO Agios Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 18, 2026 | AGIO Agios Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 13, 2026 | AGIO Agios Pharmaceuticals, Inc | Bought (not open market) | — |
| Oct 27, 2025 | NEOG Neogen Corp | Bought (not open market) | $12.5K |
| Oct 27, 2025 | NEOG Neogen Corp | Bought (not open market) | $11K |
| Oct 23, 2025 | NEOG Neogen Corp | Bought (not open market) | $120K |
| Oct 23, 2025 | NEOG Neogen Corp | Bought (not open market) | — |
| Oct 7, 2025 | NEOG Neogen Corp | Bought (not open market) | $11.7K |
Companies traded
- AGIO Agios Pharmaceuticals, Inc: other filings, last Jun 18, 2026
- NEOG Neogen Corp: 1 buy, last Oct 27, 2025
- BIIB Biogen Inc: other filings, last Feb 12, 2020
- OVAS OvaScience, Inc: other filings, last Jul 4, 2018
- FLKS Flex Pharma, Inc: other filings, last Jul 26, 2017
- BSX Boston Scientific Corp: 7 sales, last Nov 27, 2013
- OVSC OvaScience, Inc: 1 buy, last Mar 18, 2013